Table 2.
Laboratory and radiological findings of COVID-19 patients at admission.
| Variable | Total (N = 258) |
DM (n = 63) |
Non-DM (n = 195) |
P |
|---|---|---|---|---|
| WBC (×109/L), median (IQR) | 5.64 (4.37, 7.39) | 6.34 (4.66, 8.15) | 5.45 (4.31,7.19) | 0.039 |
| >9.5 × 109/L, n (%) | 26 (10.1) | 13 (20.6) | 13 (6.7) | 0.004 |
| 3.5–9.5 × 109/L, n (%) | 209 (81.0) | 47 (74.6) | 162 (83.1) | |
| <3.5× 109/L, n (%) | 23 (8.9) | 3 (4.8) | 20 (10.3) | |
| Neutrophil (×109/L), median (IQR) | 3.92 (2.85, 5.83) | 4.49 (3.12, 6.91) | 3.82 (2.81, 5.39) | 0.022 |
| Lymphocyte (×109/L), median (IQR) | 1.01 (0.71, 1.38) | 1.1 (0.65, 1.41) | 0.995 (0.72, 1.37) | 0.655 |
| <1.1 × 109/L, n (%) | 146 (56.6) | 30 (47.6) | 116 (59.5) | 0.099 |
| Lymphocyte percentage (%), median (IQR) | 18.4 (11.63, 26.08) | 16.4 (9.05, 25.1) | 18.65 (12.3, 26.7) | 0.118 |
| <20%, n (%) | 150 (58.1) | 41 (65.1) | 109 (55.9) | 0.199 |
| NLR, median (IQR) | 3.95 (2.47, 7.07) | 4.56 (2.69, 9.51) | 3.8 (2.25, 6.31) | 0.043 |
| Eosinophil (×109/L), median (IQR) | 0.03 (0, 0.07) | 0.02 (0, 0.08) | 0.03 (0, 0.07) | 0.553 |
| <0.02 × 109/L, n (%) | 111 (43.0) | 29 (46.0) | 82 (42.1) | 0.579 |
| CRP (mg/L), median (IQR) | 30.75 (4.94, 69.17) | 30.75 (4.53, 81.72) | 30.68 (5.75, 67.37) | 0.765 |
| PCT (ng/ml), median (IQR) | 0.07 (0.05, 0.14) | 0.07 (0.05, 0.26) | 0.07 (0.04, 0.13) | 0.116 |
| LDH (U/L), median (IQR) | 268.5 (206, 355.75) | 318 (195.5, 426.3) | 264.5 (207, 338) | 0.205 |
| FBG (mmol/L), median (IQR) | 6.04 (5.41, 7.20) | 7.54 (6.37, 10.62) | 5.81 (5.32, 6.59) | <0.001 |
| CREA (μmol/L), median (IQR) | 69.6 (57.93, 79.9) | 74 (64.25, 95.78) | 67.8 (57.2, 78.23) | 0.005 |
| BUN (mmol/L), median (IQR) | 4.65 (3.66, 6.34) | 5.9 (4.09, 8.62) | 4.41 (3.58, 5.57) | <0.001 |
| CK-MB (U/L), median (IQR) | 12 (9, 15) | 14 (10, 17) | 11 (9, 14) | 0.042 |
| D-Dimer (μg/mL), median (IQR) | 0.56 (0.27, 1.62) | 0.87 (0.35, 2.46) | 0.54 (0.25, 1.51) | 0.046 |
| PT (sec), median (IQR) | 13 (12.3, 13.9) | 12.05 (12.8, 14) | 13(12.4, 13.9) | 0.394 |
| APTT (sec), median (IQR) | 36.75 (33.45, 40.65) | 37 (32.55, 42.55) | 36.6 (33.65, 40.5) | 0.760 |
| TT (sec), median (IQR) | 15.6 (14.93, 16.3) | 16.1 (15.25, 16.65) | 15.5 (14.9, 16.23) | 0.035 |
| INR, median (IQR) | 1 (0.94, 1.09) | 0.98 (0.91, 1.1) | 1 (0.94, 1.09) | 0.326 |
| Abnormal Chest CT images, n (%) | 254 (98.4) | 62 (98.4) | 192 (98.5) | 0.978 |
| Bilateral lung involved | 247 (95.7) | 60 (95.2) | 187 (95.9) | |
| Left lung involved only | 3 (1.2) | 1 (1.6) | 2 (1.0) | |
| Right lung involved only | 4 (1.6) | 1 (1.6) | 3 (1.5) |
DM, diabetes mellitus; IQR, interquartile range; WBC, white blood cell; NLR, neutrophil-to-lymphocyte ratio; CRP, C-reactive protein; PCT, procalcitonin; LDH, lactate dehydrogenase; FBG, fasting blood glucose; CREA, serum creatine; BUN, blood Urea nitrogen; CK-MB, creatine kinase isoenzyme MB; PT, prothrombin time; APTT, activated partial thromboplastin time; TT, thrombin time; INR, international normalized ratio.